Preeclampsia is pregnancy-specific, and significantly contributes to maternal, and perinatal
morbidity and mortality worldwide. An effective predictive test for preeclampsia would …

BACKGROUND Despite significant advances in our understanding of the pathophysiology
of preeclampsia (PE), there are still many unknowns and controversies in the field. Women …

Preeclampsia is a complex disease of pregnancy whose physiopathology remains unclear.
We developed machine-learning models for early prediction of preeclampsia (first 16 weeks …

Human placenta is a complex and heterogeneous organ interfacing between the mother
and the fetus that supports fetal development. Alterations to placental structural components …

Proper development of the placenta is vital for pregnancy success. The placenta regulates
exchange of nutrients and gases between maternal and fetal blood and produces hormones …

Fetal growth restriction (FGR) is one of the most formidable challenges in present-day
antenatal care. Pathological fetal growth is a well-known factor of not only in utero demise in …

Most of maternal deaths are preventable, and one-quarter of maternal deaths are due to pre-
eclampsia and eclampsia. Prenatal screening is essential for detecting and managing pre …

Preeclampsia (PE) and Intrauterine Growth Restriction (IUGR) are major contributors to
perinatal morbidity and mortality. These pregnancy disorders are associated with placental …

Preeclampsia (PE) and fetal growth restriction (FGR) are both placenta-mediated disorders
with unclear pathogenesis. Metabolomics of maternal and fetal pairs might help in …

Preeclampsia is a pregnancy-specific syndrome characterized by hypertension and
proteinuria after 20 weeks of gestation. However, it is not well understood what lipids are …